Texas hospitals must ensure their affiliated physicians, pharmacists and health plans adhere to and are aware of state laws and best practices related to the new Prescription Monitoring Program and contract requirements for prescription drug benefits provided by Medicaid managed care organizations, among others. The Texas Hospital Association is tracking the legislature’s efforts to:

  • Evaluate recent efforts in Texas and in other states to enhance transparency regarding the practices of pharmacy benefit managers. House Committee on Insurance
  • Examine the impacts of changes in prescription drug coverage and drug formularies on patients, particularly those with chronic conditions. House Committee on Insurance
  • Monitor and evaluate the implementation of legislation (House Bill 2561) related to the Prescription Monitoring Program. In addition, review the prescribing of addictive drugs by physicians and other health care providers within various geographic regions of this state. Determine the role of health care professionals in preventing overutilization and diversion of addictive prescriptions. Provide recommendations that will improve efforts to prevent overutilization and diversion of addictive prescriptions. House Select Committee on Opioids and Substance Abuse


Jennifer Banda, vice president of advocacy, public policy and HOSPAC, 512/465-1046

Sara Gonzalez, vice president of advocacy and public policy, 512/465-1596

Cesar Lopez, J.D., associate general counsel, 512/465-1027

Sharon Beasley, legal manager, 512/465-1030